Bioavailability and pharmacokinetics of an oral dopamine prodrug in dogs
β Scribed by Kazuo Murata; Kazuo Noda; Keiichi Kohno; Masayoshi Samejima
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 270 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pharmacokinetic compartment models were constructed to describe the absorption and metabolism of dopamine (DA) and DA prodrug, N-(N-acetyl-L-methionyl)O,O-bis(ethoxycarbonyl) dopamine( 1). Plasma concentrations of DA, DA-SO,, and DOPAC after oral administration of DA to dogs, were analysed using the
## Abstract A pharmacokinetic study of carbimide, an inhibitor of aldehyde dehydrogenase, used as an adjuvant in the aversive therapy of chronic alcoholism, has been carried out in male human volunteers for intravenous and oral administration. Carbimide plasma concentrations were determined by a se
The aim of this investigation was to assess the pharmacokinetics and bioavailability of ergometrine in six human male subjects after an oral dose of 0.200 mg and after an intravenous dose of 0.075 mg of ergometrine maleate. A large variation in bioavailability of between 34% and 117% in the six volu